NVN Liquidation Past Earnings Performance

Past criteria checks 0/6

NVN Liquidation has been growing earnings at an average annual rate of 6.1%, while the Pharmaceuticals industry saw earnings declining at 0.9% annually. Revenues have been growing at an average rate of 512.7% per year.

Key information

6.1%

Earnings growth rate

29.0%

EPS growth rate

Pharmaceuticals Industry Growth14.1%
Revenue growth rate512.7%
Return on equityn/a
Net Margin-128.6%
Last Earnings Update31 Mar 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How NVN Liquidation makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

LSE:0A4P Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2325-32380
31 Dec 2224-31340
30 Sep 2214-37310
30 Jun 229-37260
31 Mar 224-34160
31 Dec 213-30120
30 Sep 213-28110
30 Jun 214-30110
31 Mar 215-32110
31 Dec 205-29110
30 Sep 205-29113
30 Jun 205-30107
31 Mar 205-301011
31 Dec 195-301015
30 Sep 198-171115
30 Jun 197-151215
31 Mar 196-141215
31 Dec 186-131215
30 Sep 183-281115
30 Jun 183-281115
31 Mar 183-301211
31 Dec 173-371314
30 Sep 172-421413
30 Jun 171-521411
31 Mar 170-601413
31 Dec 160-60139
30 Sep 160-57138
30 Jun 160-45137
31 Mar 160-32116
31 Dec 150-2695
30 Sep 15-3-2172
31 Dec 140-1352
31 Dec 133-643

Quality Earnings: 0A4P is currently unprofitable.

Growing Profit Margin: 0A4P is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if 0A4P's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare 0A4P's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 0A4P is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (2.6%).


Return on Equity

High ROE: 0A4P's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies